You have 9 free searches left this month | for more free features.

MAB 124I-omburtamab

Showing 26 - 50 of 306

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Plasmodium Falciparum Infection, Malaria Trial in Faladje, Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal Saline)

Not yet recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • L9LS (VRC-MALMAB0114-00-AB)
  • Normal Saline
  • Faladje, Région De Koulikoro, Mali
  • +2 more
Apr 17, 2023

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Advanced or Metastatic Solid Tumors Trial (PMC-309 monotherapy, PMC-309 Dose Escalation in Combination with Pembrolizumab,

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • PMC-309 monotherapy
  • +2 more
  • (no location specified)
Jul 19, 2023

COVID-19, SARS-CoV-2 Trial in Moscow, St Petersburg (Biological: AZD3152, Biological: Placebo)

Not yet recruiting
  • COVID-19, SARS-CoV-2
  • Biological: AZD3152
  • Biological: Placebo
  • Moscow, Russian Federation
  • +5 more
Sep 26, 2023

Non-Hodgkin's Lymphoma, Myeloma, Active Solid Malignancy Trial in New York (PET Imaging using 124 IPUH71)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • PET Imaging using 124 IPUH71
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • COVID-19 vaccine
  • Montréal, Quebec, Canada
  • +1 more
Jan 13, 2023

Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

Recruiting
  • Migraine
  • +4 more
  • Innsbruck, Tirol, Austria
  • +2 more
Oct 19, 2022

Malaria Trial in Baltimore (MAM01, Placebo)

Not yet recruiting
  • Malaria
  • MAM01
  • Placebo
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023

Cachexia Trial (AV-380)

Not yet recruiting
  • Cachexia
  • AV-380
  • (no location specified)
May 9, 2023

Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

Not yet recruiting
  • Hepatitis b Virus
  • HepB mAb19
  • Sterile Saline
  • New York, New York
  • +1 more
May 12, 2023

NPC Trial in Guangzhou (Sintilimab, IBI310)

Active, not recruiting
  • NPC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 3, 2022

Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)

Recruiting
  • Breast Cancer
  • Chidamide Plus Toripalimab Plus Paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 19, 2023

Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate

Recruiting
  • Metastatic Prostate Cancer
  • Liquid Biopsy
  • Archival Tumor DNA sequencing
  • Barcelona, Spain
    SOLTI Cancer Research Group
May 22, 2023

Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)

Active, not recruiting
  • Melanoma
  • +2 more
  • 124I-Humanized 3F8
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 1, 2022

Solid Tumor, Adult Trial in Australia (IOS-1002, IOS-1002 + PD-1 mAb)

Recruiting
  • Solid Tumor, Adult
  • Clayton, Australia
  • +4 more
Mar 15, 2023

Healthy Volunteers Trial in Shanghai (ZB001 for injection)

Not yet recruiting
  • Healthy Volunteers
  • ZB001 for injection
  • Shanghai, China
    Shanghai Mental Health Center
Sep 13, 2022

Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Kurralta Park, South Australia, Australia
  • +1 more
Nov 9, 2022

Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)

Active, not recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • VRC-MALMAB0100-00-AB (CIS43LS)
  • Normal saline
  • Kalifabougou, Région De Koulikoro, Mali
  • +1 more
Sep 20, 2022

Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Endostatin
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
Jul 4, 2022

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,

Active, not recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

Withdrawn
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Elotuzumab, Selinexor, and Dexamethasone (ESd)
  • (no location specified)
Apr 27, 2022

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Plasmodium Falciparum Infection, Malaria Trial in Kisumu (L9LS, Normal Saline)

Recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • Kisumu, Kenya
    Kenya Medical Research Institute (KEMRI) Center for Global Healt
Sep 15, 2022

Advanced or Metastatic Solid Tumors Trial in Toulouse, Villejuif, Barcelona (W0101 - Cohort A1, W0101 - Cohort A2, W0101 -

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • W0101 - Cohort A1
  • +2 more
  • Toulouse, France
  • +2 more
Dec 19, 2022

Ovarian Tumors, Endometrial Tumors, Breast Tumors Trial in Puerto Rico, United States (PF-07260437, B7-H4 IHC)

Recruiting
  • Ovarian Neoplasms
  • +2 more
  • Duarte, California
  • +13 more
Jan 19, 2023